LANCHBURY JERRY S
SEC CIK 1219036 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | CSO | 264.3K | — | $13.12M | 17 | 2021-07-07 | 2021-10-09 |
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
LANCHBURY JERRY S made no open-market trades at MYGN in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-12 | 2021-10-09 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | F - Tax | $30.88 | -10.8K | 264.3K | -4% | -$333.8K |
| 2021-09-27 | 2021-09-23 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale | $35.06 | -200 | 288.5K | -0.1% | -$7,012 | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | F - Tax | $33.31 | -13.4K | 278.8K | -5% | -$445.7K |
| 2021-09-23 | 2021-09-21 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | A - Grant | $0.00 | +58.4K | 288.7K | +25% | $0 | |
| 2021-08-26 | 2021-08-25 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | F - Tax | $34.81 | -2,233 | 230.3K | -1.0% | -$77.7K | |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $35.32 | -80.0K | 232.6K | -26% | -$2.83M |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $27.07 | +80.0K | 262.6K | +44% | +$2.17M |
| D | 2021-08-06 | 2021-08-05 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $27.07 | +28.2K | 260.8K | +12% | +$764.1K |
| D | 2021-08-06 | 2021-08-05 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $35.57 | -28.2K | 232.6K | -11% | -$1.00M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $25.99 | +100.0K | 260.4K | +62% | +$2.60M |
| DM | 2021-08-05 | 2021-08-03+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $34.68 | -100.0K | 232.6K | -30% | -$3.47M |
| DM | 2021-07-14 | 2021-07-12+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $33.64 | -93.3K | 232.6K | -29% | -$3.14M |
| DM | 2021-07-14 | 2021-07-12+ | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $26.49 | +93.3K | 272.6K | +52% | +$2.47M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.62 | -50.0K | 232.6K | -18% | -$1.63M |
| DM | 2021-07-12 | 2021-07-09 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $24.01 | +50.0K | 259.3K | +24% | +$1.20M |
| DM | 2021-07-08 | 2021-07-07 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | M - OptEx | $26.49 | +32.3K | 234.4K | +16% | +$855.8K |
| DM | 2021-07-08 | 2021-07-07 | MYGN | MYRIAD GENETICS INC | LANCHBURY JERRY S | CSO | S - Sale+OE | $32.27 | -32.3K | 232.6K | -12% | -$1.04M |
Purchase Sale Sale after option exercise All abbreviations